Tags

Type your tag names separated by a space and hit enter

Bone mineral disorder in chronic kidney disease: Klotho and FGF23; cardiovascular implications.
Nefrologia. 2016 Jul-Aug; 36(4):368-75.N

Abstract

Cardiovascular factors are one of the main causes of morbidity and mortality in patients with chronic kidney disease. Bone mineral metabolism disorders and inflammation are pathological conditions that involve increased cardiovascular risk in chronic kidney disease. The cardiovascular risk involvement of bone mineral metabolism classical biochemical parameters such as phosphorus, calcium, vitamin D and PTH is well known. The newest markers, FGF23 and klotho, could also be implicated in cardiovascular disease.

Authors+Show Affiliations

Servicio de Nefrología, Hospital de La Princesa, Madrid, España. Electronic address: aelita.sv@gmail.com.Servicio de Nefrología, Hospital de La Princesa, Madrid, España.Servicio de Nefrología, Hospital de La Princesa, Madrid, España.Servicio de Nefrología, Hospital de La Princesa, Madrid, España.Servicio de Nefrología, Hospital de La Princesa, Madrid, España.

Pub Type(s)

Journal Article
Review

Language

eng spa

PubMed ID

27118192

Citation

Salanova Villanueva, Laura, et al. "Bone Mineral Disorder in Chronic Kidney Disease: Klotho and FGF23; Cardiovascular Implications." Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia, vol. 36, no. 4, 2016, pp. 368-75.
Salanova Villanueva L, Sánchez González C, Sánchez Tomero JA, et al. Bone mineral disorder in chronic kidney disease: Klotho and FGF23; cardiovascular implications. Nefrologia. 2016;36(4):368-75.
Salanova Villanueva, L., Sánchez González, C., Sánchez Tomero, J. A., Aguilera, A., & Ortega Junco, E. (2016). Bone mineral disorder in chronic kidney disease: Klotho and FGF23; cardiovascular implications. Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia, 36(4), 368-75. https://doi.org/10.1016/j.nefro.2016.01.011
Salanova Villanueva L, et al. Bone Mineral Disorder in Chronic Kidney Disease: Klotho and FGF23; Cardiovascular Implications. Nefrologia. 2016 Jul-Aug;36(4):368-75. PubMed PMID: 27118192.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Bone mineral disorder in chronic kidney disease: Klotho and FGF23; cardiovascular implications. AU - Salanova Villanueva,Laura, AU - Sánchez González,Carmen, AU - Sánchez Tomero,José Antonio, AU - Aguilera,Abelardo, AU - Ortega Junco,Esther, Y1 - 2016/04/23/ PY - 2015/06/22/received PY - 2015/12/17/revised PY - 2016/01/02/accepted PY - 2016/4/28/entrez PY - 2016/4/28/pubmed PY - 2017/12/9/medline KW - Cardiovascular risk KW - Chronic kidney disease KW - Enfermedad renal crónica KW - FGF23 KW - Klotho KW - Riesgo cardiovascular SP - 368 EP - 75 JF - Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia JO - Nefrologia VL - 36 IS - 4 N2 - Cardiovascular factors are one of the main causes of morbidity and mortality in patients with chronic kidney disease. Bone mineral metabolism disorders and inflammation are pathological conditions that involve increased cardiovascular risk in chronic kidney disease. The cardiovascular risk involvement of bone mineral metabolism classical biochemical parameters such as phosphorus, calcium, vitamin D and PTH is well known. The newest markers, FGF23 and klotho, could also be implicated in cardiovascular disease. SN - 1989-2284 UR - https://www.unboundmedicine.com/medline/citation/27118192/Bone_mineral_disorder_in_chronic_kidney_disease:_Klotho_and_FGF23 L2 - http://www.revistanefrologia.com/es/linksolver/ft/pii/S0211-6995(16)30007-8 DB - PRIME DP - Unbound Medicine ER -